VPC-13789 is a highly potent, selective, and orally bioavailable antiandrogen compound that shows promise for studying and developing therapeutics for castration-resistant prostate cancer (CRPC). In LNCaP cells, VPC-13789 effectively inhibits the transcriptional activity of the androgen receptor (AR) with an IC50 value of 0.19 µM [1].
Molecular Weight:
383.37
CAS Number:
[2761146-51-2]
Formula:
C21H16F3N3O
Target:
Others|||Androgen Receptor
T61653
* VAT and and shipping costs not included. Errors and price changes excepted